Company intelligence / Profile preview
CARsgen Therapeutics
Shanghai, Shanghai, Chinacarsgen.com ↗
- Ownership
- Public · 2171.HK
- Employees
- ~500
- Development stage
- Commercial
01
Overview
CARsgen has achieved significant clinical milestones:
- Zevor-cel approved by NMPA in China.
- Satri-cel (CT041) completed confirmatory Phase II trial enrollment in China with positive topline results for advanced gastric/gastroesophageal junction cancers after at least two prior lines of therapy.
- Multiple adjuvant studies and early-phase trials underway for both hematologic malignancies and solid tumors.
- Active development of allogeneic pipeline products.
- Therapeutic areas
- OncologyImmunology
- Modalities
- CAR T-cell therapies (autologous and allogeneic)cell therapy
- Industry
- Biotech
02
Drug pipeline
49 assets48 more assets in the full pipeline.
03
Partnerships
Collaboration with Moderna to investigate combination of Moderna’s investigational Claudin18.2 mRNA product with satri-celAcademic collaborations not detailed but implied via investigator-led studies.
04
Financials
- Market cap
- $825.4M
- Total revenue
- $18.8M
- Enterprise value
- $626.4M
Beyond the preview
Go deeper on CARsgen Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CARsgen Therapeutics.